Ashley Lombardo · May 22, 2017
MedTruth Weekly is an update on consumer safety campaigns, covering regulations, settlements, studies, legislation and more.
Health FeaturesAshley Lombardo · September 8, 2017
While this diabetes drug is known to help lower blood sugar, many hopeful patients are also wondering why does Invokana cause amputations.
Health FeaturesAshley Lombardo · September 15, 2017
Invokana's amputation risk discourages doctors, investigators uncover unreported nursing home abuse, and an EU Roundup report is questioned.
Health FeaturesAshley Lombardo · May 22, 2017
MedTruth Weekly is an update on consumer safety campaigns, covering regulations, settlements, studies, legislation and more.
Health FeaturesAshley Lombardo · September 8, 2017
While this diabetes drug is known to help lower blood sugar, many hopeful patients are also wondering why does Invokana cause amputations.
Health FeaturesAshley Lombardo · September 15, 2017
Invokana's amputation risk discourages doctors, investigators uncover unreported nursing home abuse, and an EU Roundup report is questioned.
Health FeaturesAshley Lombardo · November 10, 2017
IVC filter use declines, synthetic hernia mesh fails again, and mental health services are expanded for veterans.
Health FeaturesAshley Lombardo · July 20, 2017
In this edition of MedTruth Weekly, we discuss Medicaid cuts to nursing homes, Essure's removal from Canadian markets, and more.
Health FeaturesAshley Lombardo · October 13, 2017
MedTruth examines why Monsanto is banned from European lobbying, how testosterone impacts stock markets, and a new possible use for Invokana.
Health FeaturesJames Parker · April 3, 2020
The FDA released a warning about continuing the use of sodium-glucose co-transporter-2 inhibitors before surgery, informing patients that the class of diabetes medications could contribute to a higher risk of ketoacidosis.
FDA RegulationCrystal Duan · May 2, 2019
Male diabetic patients may have to watch out for Fournier's gangrene linked to type 2 diabetes medications known as SGLT-2 inhibitors, according to August 2018 announcement from the FDA.
Health FeaturesJames Parker · September 17, 2018
People with diabetes taking Invokana and other SGLT2 inhibitors may be at risk for Fournier's gangrene, a flesh-eating bacterial infection affecting the groin and genitals. SGLT2 inhibitors that may potentially cause Fournier's gangrene include Invokana, Farxiga and Jardiance.
FDA RegulationAshley Lombardo · November 20, 2017
Do you know someone with diabetes? Check out our tips on how to provide solid diabetes support to friends and family.
Health FeaturesAshley Lombardo · February 24, 2018
Online pharmacies are cheap and convenient. But if you don't know how to buy medicine online, are internet pharmacies actually safe?
Health FeaturesAshley Lombardo · November 10, 2017
IVC filter use declines, synthetic hernia mesh fails again, and mental health services are expanded for veterans.
Health FeaturesAshley Lombardo · May 22, 2017
MedTruth Weekly is an update on consumer safety campaigns, covering regulations, settlements, studies, legislation and more.
Health FeaturesAshley Lombardo · July 20, 2017
In this edition of MedTruth Weekly, we discuss Medicaid cuts to nursing homes, Essure's removal from Canadian markets, and more.
Health FeaturesAshley Lombardo · September 8, 2017
While this diabetes drug is known to help lower blood sugar, many hopeful patients are also wondering why does Invokana cause amputations.
Health FeaturesAshley Lombardo · December 22, 2017
In this edition of MT Weekly, a new life-prolonging pill may help those with ovarian cancer, a vaginal mesh scare in the U.K., and more.
Health FeaturesAshley Lombardo · November 8, 2017
MedTruth's National Diabetes Month focus is educating patients on how to handle diabetes drug side effects.
Health FeaturesAshley Lombardo · September 15, 2017
Invokana's amputation risk discourages doctors, investigators uncover unreported nursing home abuse, and an EU Roundup report is questioned.
Health FeaturesAshley Lombardo · October 13, 2017
MedTruth examines why Monsanto is banned from European lobbying, how testosterone impacts stock markets, and a new possible use for Invokana.
Health FeaturesAshley Lombardo · February 13, 2017
On Dec. 7, 2016, the U.S. Judicial Panel on Multidistrict Litigation ordered the cases be joined into a multidistrict legislation (MDL). More than 50 Invokana lawsuits related to the controversial diabetes drug have been consolidated in a U.S. District Court of New Jersey.
Legal DevelopmentsAshley Lombardo · July 24, 2016
The Food and Drug Administration (FDA) has updated warnings on four diabetes medications to minimize the risk of acute kidney injury. Used to treat type II diabetes, canagliflozin and dapagliflozin are sodium-glucose cotransporter-2 (SGLT2) inhibitors that work with the kidneys to maintain safe blood sugar levels.
FDA RegulationAshley Lombardo · June 24, 2016
On March 31, 2015, Public Citizen issued a petition to encourage the FDA to take action and regulate misleading Invokana ads.
FDA RegulationBenjamin Duong · February 12, 2019
A popular class of diabetes medications in 2019 may cause an increased risk of amputation, in addition to other complications such as diabetic ketoacidosis, acute kidney injury and serious urinary tract infection, SGLT2 amputation creates another risk for patients with diabetes.
FDA RegulationFebruary 24, 2018
November 10, 2017
July 20, 2017
December 22, 2017
November 8, 2017
October 13, 2017
February 13, 2017
June 24, 2016
February 12, 2019